论文部分内容阅读
目的探讨β2受体激动剂与抗胆碱能药物治疗慢性阻塞性肺疾病(COPD)的临床效果。方法选取2014年2~9月收治的COPD患者76例。随机分为观察组与对照组各38例。对照组采用常规方法治疗,观察组采用β2受体激动剂与抗胆碱能药物治疗,比较2组临床疗效。结果观察组FVC、FEV1及FEV1/FVC指标均明显高于对照组,差异有统计学意义(P<0.05)。对照组总有效率71.05%明显低于观察组的94.74%,差异有统计学意义(P<0.05)。结论β2受体激动剂与抗胆碱能药物治疗COPD可有效缓解患者临床症状,促进肺功能恢复,提高临床效果,改善患者生存质量,值得临床推广应用
Objective To investigate the clinical effect of β2 receptor agonists and anticholinergic drugs on chronic obstructive pulmonary disease (COPD). Methods 76 patients with COPD admitted from February to September in 2014 were selected. Randomly divided into observation group and control group, 38 cases each. The control group was treated by conventional method. The observation group was treated with β2 receptor agonist and anticholinergic drugs. The clinical efficacy was compared between the two groups. Results The indexes of FVC, FEV1 and FEV1 / FVC in the observation group were significantly higher than those in the control group, with statistical significance (P <0.05). The total effective rate in the control group was 71.05%, which was significantly lower than that in the observation group (94.74%), the difference was statistically significant (P <0.05). Conclusion The treatment of COPD with β2 agonists and anticholinergic drugs can effectively relieve the clinical symptoms, promote the recovery of pulmonary function, improve the clinical effect and improve the quality of life of patients, which is worthy of clinical application